Structure

Physi-Chem Properties

Molecular Weight:  472.36
Volume:  520.462
LogP:  5.429
LogD:  4.359
LogS:  -4.215
# Rotatable Bonds:  5
TPSA:  77.76
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.398
Synthetic Accessibility Score:  4.96
Fsp3:  0.833
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.296
MDCK Permeability:  1.2927302122989204e-05
Pgp-inhibitor:  0.331
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.921
30% Bioavailability (F30%):  0.885

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.391
Plasma Protein Binding (PPB):  94.64962005615234%
Volume Distribution (VD):  0.683
Pgp-substrate:  3.4178361892700195%

ADMET: Metabolism

CYP1A2-inhibitor:  0.008
CYP1A2-substrate:  0.247
CYP2C19-inhibitor:  0.016
CYP2C19-substrate:  0.932
CYP2C9-inhibitor:  0.113
CYP2C9-substrate:  0.967
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.252
CYP3A4-inhibitor:  0.053
CYP3A4-substrate:  0.125

ADMET: Excretion

Clearance (CL):  10.432
Half-life (T1/2):  0.191

ADMET: Toxicity

hERG Blockers:  0.058
Human Hepatotoxicity (H-HT):  0.689
Drug-inuced Liver Injury (DILI):  0.015
AMES Toxicity:  0.003
Rat Oral Acute Toxicity:  0.951
Maximum Recommended Daily Dose:  0.975
Skin Sensitization:  0.713
Carcinogencity:  0.141
Eye Corrosion:  0.005
Eye Irritation:  0.052
Respiratory Toxicity:  0.937

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC173272

Natural Product ID:  NPC173272
Common Name*:   15R-Hydroxytrametenolic Acid
IUPAC Name:   (2R)-2-[(3S,5R,10S,13R,14R,15S,17R)-3,15-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid
Synonyms:   15R-Hydroxytrametenolic Acid
Standard InCHIKey:  QQFMRSAZKNSIDN-JZTHNVADSA-N
Standard InCHI:  InChI=1S/C30H48O4/c1-18(2)9-8-10-19(26(33)34)22-17-25(32)30(7)21-11-12-23-27(3,4)24(31)14-15-28(23,5)20(21)13-16-29(22,30)6/h9,19,22-25,31-32H,8,10-17H2,1-7H3,(H,33,34)/t19-,22-,23+,24+,25+,28-,29-,30-/m1/s1
SMILES:  CC(=CCC[C@H]([C@H]1C[C@@H]([C@@]2([C@]1(C)CCC1=C2CC[C@@H]2[C@]1(C)CC[C@@H](C2(C)C)O)C)O)C(=O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL482587
PubChem CID:   44575773
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8498 Laetiporus sulphureus Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[15620242]
NPO8498 Laetiporus sulphureus Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[19842686]
NPO8498 Laetiporus sulphureus Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13025 Senecio lanceus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11286 Helichrysum bilobum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9732 Glochidion heyneanum Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 = 12000.0 nM PMID[488946]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC173272 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9888 High Similarity NPC48330
0.9444 High Similarity NPC206810
0.9355 High Similarity NPC477854
0.9348 High Similarity NPC477853
0.9271 High Similarity NPC477812
0.9213 High Similarity NPC242864
0.913 High Similarity NPC166906
0.9121 High Similarity NPC23434
0.9101 High Similarity NPC187376
0.9101 High Similarity NPC159046
0.9101 High Similarity NPC233836
0.9043 High Similarity NPC190554
0.9032 High Similarity NPC45324
0.9032 High Similarity NPC470016
0.9032 High Similarity NPC162001
0.9032 High Similarity NPC222845
0.9032 High Similarity NPC317586
0.9022 High Similarity NPC470375
0.9022 High Similarity NPC477855
0.9022 High Similarity NPC470376
0.8989 High Similarity NPC28252
0.8989 High Similarity NPC55309
0.898 High Similarity NPC231530
0.898 High Similarity NPC278628
0.8947 High Similarity NPC114274
0.8936 High Similarity NPC95565
0.8936 High Similarity NPC305483
0.8936 High Similarity NPC96859
0.8936 High Similarity NPC42042
0.8936 High Similarity NPC328162
0.8913 High Similarity NPC26888
0.8901 High Similarity NPC102414
0.8901 High Similarity NPC77168
0.8901 High Similarity NPC84271
0.8901 High Similarity NPC474704
0.8901 High Similarity NPC475921
0.8889 High Similarity NPC474684
0.8889 High Similarity NPC142361
0.8866 High Similarity NPC271980
0.8866 High Similarity NPC193934
0.8854 High Similarity NPC15390
0.8842 High Similarity NPC108078
0.8842 High Similarity NPC320306
0.883 High Similarity NPC69548
0.883 High Similarity NPC469599
0.883 High Similarity NPC184848
0.8812 High Similarity NPC197428
0.8804 High Similarity NPC148414
0.8804 High Similarity NPC111585
0.8804 High Similarity NPC175628
0.8804 High Similarity NPC469400
0.88 High Similarity NPC94529
0.8778 High Similarity NPC155011
0.8776 High Similarity NPC55872
0.8776 High Similarity NPC140723
0.875 High Similarity NPC477813
0.875 High Similarity NPC48647
0.875 High Similarity NPC186810
0.875 High Similarity NPC197386
0.8723 High Similarity NPC469406
0.8723 High Similarity NPC111015
0.871 High Similarity NPC189520
0.871 High Similarity NPC297265
0.87 High Similarity NPC472925
0.8696 High Similarity NPC54689
0.8696 High Similarity NPC86319
0.8696 High Similarity NPC275740
0.8696 High Similarity NPC474889
0.8687 High Similarity NPC28656
0.8687 High Similarity NPC96268
0.8681 High Similarity NPC312215
0.8673 High Similarity NPC195290
0.8673 High Similarity NPC204450
0.866 High Similarity NPC83709
0.866 High Similarity NPC218383
0.866 High Similarity NPC316964
0.866 High Similarity NPC327431
0.8646 High Similarity NPC43747
0.8632 High Similarity NPC173875
0.8632 High Similarity NPC279974
0.8632 High Similarity NPC174948
0.8632 High Similarity NPC469995
0.8632 High Similarity NPC127063
0.8632 High Similarity NPC473240
0.8632 High Similarity NPC318282
0.8617 High Similarity NPC66429
0.8617 High Similarity NPC152897
0.8617 High Similarity NPC25750
0.8602 High Similarity NPC20388
0.8602 High Similarity NPC289213
0.8602 High Similarity NPC471896
0.86 High Similarity NPC323834
0.8587 High Similarity NPC131470
0.8587 High Similarity NPC294480
0.8587 High Similarity NPC471722
0.8587 High Similarity NPC143767
0.8586 High Similarity NPC236390
0.8586 High Similarity NPC191892
0.8586 High Similarity NPC159442
0.8571 High Similarity NPC94755
0.8571 High Similarity NPC212843
0.8571 High Similarity NPC472924
0.8542 High Similarity NPC120708
0.8542 High Similarity NPC328371
0.8542 High Similarity NPC234564
0.8542 High Similarity NPC476327
0.8542 High Similarity NPC476318
0.8542 High Similarity NPC49371
0.8526 High Similarity NPC196485
0.8526 High Similarity NPC245972
0.8515 High Similarity NPC42847
0.8515 High Similarity NPC64844
0.8511 High Similarity NPC154101
0.8511 High Similarity NPC110657
0.8511 High Similarity NPC86266
0.8511 High Similarity NPC212301
0.85 High Similarity NPC471293
0.85 High Similarity NPC29705
0.8495 Intermediate Similarity NPC186688
0.8495 Intermediate Similarity NPC128496
0.8485 Intermediate Similarity NPC22388
0.8485 Intermediate Similarity NPC293753
0.8485 Intermediate Similarity NPC473424
0.8485 Intermediate Similarity NPC234892
0.8485 Intermediate Similarity NPC473788
0.8485 Intermediate Similarity NPC475558
0.8469 Intermediate Similarity NPC110149
0.8462 Intermediate Similarity NPC280782
0.8462 Intermediate Similarity NPC71348
0.8454 Intermediate Similarity NPC18319
0.8454 Intermediate Similarity NPC189880
0.8444 Intermediate Similarity NPC278648
0.8444 Intermediate Similarity NPC476082
0.8438 Intermediate Similarity NPC263347
0.8438 Intermediate Similarity NPC200702
0.8438 Intermediate Similarity NPC472485
0.8438 Intermediate Similarity NPC255809
0.8438 Intermediate Similarity NPC472932
0.8438 Intermediate Similarity NPC241156
0.8427 Intermediate Similarity NPC473420
0.8421 Intermediate Similarity NPC69454
0.8421 Intermediate Similarity NPC470224
0.8421 Intermediate Similarity NPC170220
0.8421 Intermediate Similarity NPC244356
0.8421 Intermediate Similarity NPC141497
0.8421 Intermediate Similarity NPC107674
0.8421 Intermediate Similarity NPC224060
0.8421 Intermediate Similarity NPC243866
0.8416 Intermediate Similarity NPC149047
0.8416 Intermediate Similarity NPC196528
0.8404 Intermediate Similarity NPC46281
0.8404 Intermediate Similarity NPC183283
0.8404 Intermediate Similarity NPC136801
0.84 Intermediate Similarity NPC312900
0.84 Intermediate Similarity NPC251017
0.8387 Intermediate Similarity NPC53911
0.8387 Intermediate Similarity NPC328539
0.8387 Intermediate Similarity NPC328313
0.8387 Intermediate Similarity NPC48866
0.8387 Intermediate Similarity NPC193360
0.8387 Intermediate Similarity NPC183546
0.8387 Intermediate Similarity NPC247406
0.8384 Intermediate Similarity NPC302537
0.8384 Intermediate Similarity NPC163372
0.8381 Intermediate Similarity NPC202889
0.837 Intermediate Similarity NPC73038
0.837 Intermediate Similarity NPC474970
0.837 Intermediate Similarity NPC72133
0.8367 Intermediate Similarity NPC58942
0.8367 Intermediate Similarity NPC260149
0.8367 Intermediate Similarity NPC10364
0.8367 Intermediate Similarity NPC166745
0.8367 Intermediate Similarity NPC119036
0.8367 Intermediate Similarity NPC235464
0.8367 Intermediate Similarity NPC471717
0.8365 Intermediate Similarity NPC472928
0.8352 Intermediate Similarity NPC59453
0.8352 Intermediate Similarity NPC165064
0.8352 Intermediate Similarity NPC124172
0.8352 Intermediate Similarity NPC82902
0.8352 Intermediate Similarity NPC221758
0.8351 Intermediate Similarity NPC304899
0.8351 Intermediate Similarity NPC125622
0.8351 Intermediate Similarity NPC7124
0.8351 Intermediate Similarity NPC155676
0.8351 Intermediate Similarity NPC249954
0.8351 Intermediate Similarity NPC253115
0.8333 Intermediate Similarity NPC159365
0.8333 Intermediate Similarity NPC475060
0.8333 Intermediate Similarity NPC73882
0.8333 Intermediate Similarity NPC474922
0.8333 Intermediate Similarity NPC220229
0.8333 Intermediate Similarity NPC59530
0.8333 Intermediate Similarity NPC49670
0.8333 Intermediate Similarity NPC470957
0.8333 Intermediate Similarity NPC260956
0.8333 Intermediate Similarity NPC165873
0.8333 Intermediate Similarity NPC470958
0.8317 Intermediate Similarity NPC204833
0.8317 Intermediate Similarity NPC209502

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC173272 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8495 Intermediate Similarity NPD5328 Approved
0.8416 Intermediate Similarity NPD5739 Approved
0.8416 Intermediate Similarity NPD7128 Approved
0.8416 Intermediate Similarity NPD6675 Approved
0.8416 Intermediate Similarity NPD6402 Approved
0.8352 Intermediate Similarity NPD4786 Approved
0.8316 Intermediate Similarity NPD6079 Approved
0.8265 Intermediate Similarity NPD4755 Approved
0.8252 Intermediate Similarity NPD7320 Approved
0.8252 Intermediate Similarity NPD6899 Approved
0.8252 Intermediate Similarity NPD6881 Approved
0.8229 Intermediate Similarity NPD6399 Phase 3
0.8173 Intermediate Similarity NPD6372 Approved
0.8173 Intermediate Similarity NPD6373 Approved
0.8155 Intermediate Similarity NPD5701 Approved
0.8155 Intermediate Similarity NPD5697 Approved
0.8132 Intermediate Similarity NPD3667 Approved
0.81 Intermediate Similarity NPD5286 Approved
0.81 Intermediate Similarity NPD4696 Approved
0.81 Intermediate Similarity NPD5285 Approved
0.81 Intermediate Similarity NPD4700 Approved
0.8095 Intermediate Similarity NPD6883 Approved
0.8095 Intermediate Similarity NPD7290 Approved
0.8095 Intermediate Similarity NPD7102 Approved
0.8077 Intermediate Similarity NPD6011 Approved
0.8065 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8058 Intermediate Similarity NPD6008 Approved
0.8041 Intermediate Similarity NPD4202 Approved
0.8037 Intermediate Similarity NPD4632 Approved
0.802 Intermediate Similarity NPD5223 Approved
0.8019 Intermediate Similarity NPD6847 Approved
0.8019 Intermediate Similarity NPD6617 Approved
0.8019 Intermediate Similarity NPD6650 Approved
0.8019 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.8019 Intermediate Similarity NPD6869 Approved
0.8019 Intermediate Similarity NPD6649 Approved
0.8019 Intermediate Similarity NPD8130 Phase 1
0.8 Intermediate Similarity NPD6014 Approved
0.8 Intermediate Similarity NPD6013 Approved
0.8 Intermediate Similarity NPD7638 Approved
0.8 Intermediate Similarity NPD6012 Approved
0.798 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.798 Intermediate Similarity NPD4697 Phase 3
0.798 Intermediate Similarity NPD5222 Approved
0.798 Intermediate Similarity NPD5221 Approved
0.7979 Intermediate Similarity NPD3618 Phase 1
0.7957 Intermediate Similarity NPD3665 Phase 1
0.7957 Intermediate Similarity NPD3666 Approved
0.7957 Intermediate Similarity NPD3133 Approved
0.7944 Intermediate Similarity NPD8297 Approved
0.7944 Intermediate Similarity NPD6882 Approved
0.7941 Intermediate Similarity NPD5226 Approved
0.7941 Intermediate Similarity NPD4633 Approved
0.7941 Intermediate Similarity NPD5211 Phase 2
0.7941 Intermediate Similarity NPD5224 Approved
0.7941 Intermediate Similarity NPD5225 Approved
0.7938 Intermediate Similarity NPD7515 Phase 2
0.7921 Intermediate Similarity NPD7640 Approved
0.7921 Intermediate Similarity NPD7639 Approved
0.79 Intermediate Similarity NPD6083 Phase 2
0.79 Intermediate Similarity NPD5173 Approved
0.79 Intermediate Similarity NPD6084 Phase 2
0.7879 Intermediate Similarity NPD5695 Phase 3
0.7864 Intermediate Similarity NPD5175 Approved
0.7864 Intermediate Similarity NPD4754 Approved
0.7864 Intermediate Similarity NPD5174 Approved
0.7818 Intermediate Similarity NPD6009 Approved
0.7789 Intermediate Similarity NPD6409 Approved
0.7789 Intermediate Similarity NPD6684 Approved
0.7789 Intermediate Similarity NPD7334 Approved
0.7789 Intermediate Similarity NPD7521 Approved
0.7789 Intermediate Similarity NPD5330 Approved
0.7789 Intermediate Similarity NPD7146 Approved
0.7788 Intermediate Similarity NPD5141 Approved
0.7757 Intermediate Similarity NPD4634 Approved
0.7755 Intermediate Similarity NPD5284 Approved
0.7755 Intermediate Similarity NPD6411 Approved
0.7755 Intermediate Similarity NPD5281 Approved
0.7732 Intermediate Similarity NPD4753 Phase 2
0.7714 Intermediate Similarity NPD4767 Approved
0.7714 Intermediate Similarity NPD4768 Approved
0.7692 Intermediate Similarity NPD6115 Approved
0.7692 Intermediate Similarity NPD6118 Approved
0.7692 Intermediate Similarity NPD6114 Approved
0.7692 Intermediate Similarity NPD6697 Approved
0.7667 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD6903 Approved
0.7611 Intermediate Similarity NPD6319 Approved
0.7604 Intermediate Similarity NPD5279 Phase 3
0.76 Intermediate Similarity NPD7748 Approved
0.7589 Intermediate Similarity NPD6335 Approved
0.7579 Intermediate Similarity NPD3668 Phase 3
0.7576 Intermediate Similarity NPD8034 Phase 2
0.7576 Intermediate Similarity NPD8035 Phase 2
0.757 Intermediate Similarity NPD5128 Approved
0.757 Intermediate Similarity NPD4730 Approved
0.757 Intermediate Similarity NPD4729 Approved
0.7568 Intermediate Similarity NPD6274 Approved
0.7565 Intermediate Similarity NPD7604 Phase 2
0.7556 Intermediate Similarity NPD6942 Approved
0.7556 Intermediate Similarity NPD7339 Approved
0.7553 Intermediate Similarity NPD4223 Phase 3
0.7553 Intermediate Similarity NPD4221 Approved
0.7551 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD6101 Approved
0.7544 Intermediate Similarity NPD5983 Phase 2
0.7527 Intermediate Similarity NPD7525 Registered
0.7525 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7522 Intermediate Similarity NPD7101 Approved
0.7522 Intermediate Similarity NPD7100 Approved
0.75 Intermediate Similarity NPD5779 Approved
0.75 Intermediate Similarity NPD5778 Approved
0.75 Intermediate Similarity NPD6317 Approved
0.75 Intermediate Similarity NPD7492 Approved
0.75 Intermediate Similarity NPD5329 Approved
0.7476 Intermediate Similarity NPD5696 Approved
0.7473 Intermediate Similarity NPD6117 Approved
0.7456 Intermediate Similarity NPD6059 Approved
0.7456 Intermediate Similarity NPD6054 Approved
0.7455 Intermediate Similarity NPD6053 Discontinued
0.7449 Intermediate Similarity NPD5737 Approved
0.7449 Intermediate Similarity NPD6672 Approved
0.7436 Intermediate Similarity NPD6336 Discontinued
0.7436 Intermediate Similarity NPD6616 Approved
0.7434 Intermediate Similarity NPD6314 Approved
0.7434 Intermediate Similarity NPD6313 Approved
0.7431 Intermediate Similarity NPD5135 Approved
0.7431 Intermediate Similarity NPD5250 Approved
0.7431 Intermediate Similarity NPD5169 Approved
0.7431 Intermediate Similarity NPD5248 Approved
0.7431 Intermediate Similarity NPD5251 Approved
0.7431 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD5247 Approved
0.7431 Intermediate Similarity NPD5249 Phase 3
0.7423 Intermediate Similarity NPD5690 Phase 2
0.7423 Intermediate Similarity NPD6098 Approved
0.7423 Intermediate Similarity NPD5280 Approved
0.7423 Intermediate Similarity NPD4694 Approved
0.7411 Intermediate Similarity NPD6868 Approved
0.74 Intermediate Similarity NPD6050 Approved
0.7396 Intermediate Similarity NPD4197 Approved
0.7391 Intermediate Similarity NPD6116 Phase 1
0.7391 Intermediate Similarity NPD6909 Approved
0.7391 Intermediate Similarity NPD6908 Approved
0.7379 Intermediate Similarity NPD7902 Approved
0.7374 Intermediate Similarity NPD6673 Approved
0.7374 Intermediate Similarity NPD6904 Approved
0.7374 Intermediate Similarity NPD6080 Approved
0.7373 Intermediate Similarity NPD7078 Approved
0.7373 Intermediate Similarity NPD8293 Discontinued
0.7364 Intermediate Similarity NPD5215 Approved
0.7364 Intermediate Similarity NPD5127 Approved
0.7364 Intermediate Similarity NPD5216 Approved
0.7364 Intermediate Similarity NPD5217 Approved
0.7353 Intermediate Similarity NPD4629 Approved
0.7353 Intermediate Similarity NPD5210 Approved
0.7347 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD5368 Approved
0.734 Intermediate Similarity NPD4748 Discontinued
0.7328 Intermediate Similarity NPD6370 Approved
0.7315 Intermediate Similarity NPD6412 Phase 2
0.7311 Intermediate Similarity NPD7736 Approved
0.73 Intermediate Similarity NPD5692 Phase 3
0.7292 Intermediate Similarity NPD4788 Approved
0.7292 Intermediate Similarity NPD5362 Discontinued
0.7288 Intermediate Similarity NPD7507 Approved
0.7264 Intermediate Similarity NPD7632 Discontinued
0.7263 Intermediate Similarity NPD4139 Approved
0.7263 Intermediate Similarity NPD4692 Approved
0.7253 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD5168 Approved
0.7245 Intermediate Similarity NPD4138 Approved
0.7245 Intermediate Similarity NPD4690 Approved
0.7245 Intermediate Similarity NPD4693 Phase 3
0.7245 Intermediate Similarity NPD5205 Approved
0.7245 Intermediate Similarity NPD4689 Approved
0.7245 Intermediate Similarity NPD4688 Approved
0.7245 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6016 Approved
0.7241 Intermediate Similarity NPD6015 Approved
0.7241 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD5694 Approved
0.7193 Intermediate Similarity NPD7115 Discovery
0.7188 Intermediate Similarity NPD6435 Approved
0.7179 Intermediate Similarity NPD5988 Approved
0.7174 Intermediate Similarity NPD3703 Phase 2
0.7168 Intermediate Similarity NPD5167 Approved
0.7129 Intermediate Similarity NPD5207 Approved
0.7128 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7319 Approved
0.71 Intermediate Similarity NPD5208 Approved
0.7087 Intermediate Similarity NPD7900 Approved
0.7087 Intermediate Similarity NPD6001 Approved
0.7087 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5369 Approved
0.7071 Intermediate Similarity NPD5786 Approved
0.7065 Intermediate Similarity NPD4784 Approved
0.7065 Intermediate Similarity NPD4785 Approved
0.7059 Intermediate Similarity NPD5693 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data